Latest / Pharmacy Podcast Network / The Silent Threat: Diversion of Non-Controlled Substances in Healthcare | TWIRx
Transcript
- 0:01Speaker 1: Hey, welcome to this Weekend Pharmacy July twenty fifth, twenty
- 0:05Speaker 1: twenty five. This summer is going by so quickly, I
- 0:10Speaker 1: can't believe this. We have a lot going on today,
- 0:14Speaker 1: a lot to talk about in the news sector. We
- 0:17Speaker 1: do want to focus today on non controlled non controls
- 0:22Speaker 1: that are being diverted and how big of an issue
- 0:25Speaker 1: this is. We do have a special guest to dial
- 0:27Speaker 1: down into this. You won't want to watch.
- 0:50Speaker 2: It's twerks.
- 0:51Speaker 1: July twenty fifth, twenty twenty five. My name is Todd Uri,
- 0:55Speaker 1: founder of the Pharmacy Podcast Network. I did want to
- 0:58Speaker 1: just start right out saying we do have a special
- 1:01Speaker 1: three part series that I do want to make a
- 1:03Speaker 1: shout out to all of our pharmacy owners out there
- 1:06Speaker 1: who are interested in expanding your long term care at
- 1:10Speaker 1: home long term care pharmacy at home services. Please go
- 1:14Speaker 1: to pharmacypodcast dot com go to the news section. Three
- 1:17Speaker 1: part series by icon arc Safe. This is a wonderful
- 1:22Speaker 1: breakdown of what it means to become a paid long
- 1:28Speaker 1: term care at home pharmacy provider coming out of your
- 1:33Speaker 1: community pharmacy and some of the resources that you already
- 1:36Speaker 1: have will be leveraged and then of course all of
- 1:40Speaker 1: the parts the entire puzzle will be here for you
- 1:44Speaker 1: to listen and understand what it takes to become a
- 1:48Speaker 1: long term care pharmacy at home provider. We want to
- 1:51Speaker 1: give you as many resources as possible and I'm excited
- 1:55Speaker 1: about this series. So please take a listen, let me
- 1:58Speaker 1: know what you think, and reach out to the ARCS Safeteam.
- 2:03Speaker 1: They do a great job in guiding our pharmacy owners
- 2:06Speaker 1: to profitability. All right, Twerk's News Today is brought to
- 2:11Speaker 1: you by Independent Pharmacy Cooperative giving independent pharmacies the freedom
- 2:16Speaker 1: to farm. Great organization. You just got back from Idea
- 2:20Speaker 1: Share McKesson Idea Share. You'll be hearing a three part
- 2:23Speaker 1: series that will start next Thursday, July thirty, first last
- 2:29Speaker 1: day of July. That's my wife's birthday. Happy birthday to Nicole.
- 2:33Speaker 1: Next week, big party time, let's do it. But today
- 2:37Speaker 1: news First, let's talk about Pharmacy podcast network. If you
- 2:42Speaker 1: heard the latest from GRX Marketing Marketing against PBMs A
- 2:49Speaker 1: March to a Million. This is an amazing episode that
- 2:52Speaker 1: combines some of the insights of their team in the
- 2:56Speaker 1: medical Mafia, the modern medical Mafia and the Netflix special
- 3:02Speaker 1: as well as some of the programming and shout out
- 3:05Speaker 1: to Bill Schmidtnick and his efforts and the story of
- 3:09Speaker 1: his last son Cole because of a PBM and chain
- 3:14Speaker 1: pharmacy disaster. You just listen into this. This will give
- 3:18Speaker 1: you some perspective of how to fold against a march
- 3:23Speaker 1: against PBMs and it's a great story. Also, the series
- 3:29Speaker 1: I just told you about the last part, not your
- 3:32Speaker 1: Average Joe's two rock stars in our pharmacy community, Joe
- 3:36Speaker 1: Moose and Joe Williams are talking about how they are
- 3:39Speaker 1: expanding how they're building their long term care pharmacy business
- 3:43Speaker 1: at home. Opiodology Part one are Opioids Story. This is
- 3:49Speaker 1: from doctor Mark Garifola Garifoley the Pain Guy hashtag pain Guy.
- 3:56Speaker 1: Great episode to kick off this three part part series
- 4:00Speaker 1: on opiodology. Please definitely take a listen and expanding Holistic
- 4:07Speaker 1: Pharmacy Services Integrated Pharmacy Services. This is a great episode
- 4:12Speaker 1: from Marina Boscov, Doctor Boscov and doctor Swathy Vera Nazi.
- 4:18Speaker 1: We haven't heard from sw Swathy lately, so it's great
- 4:22Speaker 1: to hear her back on the Pharmacy Podcast Network. Hey
- 4:27Speaker 1: Shurecast is a new podcast from the Short Cost Team
- 4:32Speaker 1: breaking down the true cost of purchasing through one wholesaler
- 4:37Speaker 1: exclusively and not having the balance of resources and data
- 4:43Speaker 1: to guide you as a pharmacy owner. And this is
- 4:47Speaker 1: going to be a really interesting series that we're doing
- 4:52Speaker 1: with the Sure Cost Team. You have to listen to
- 4:55Speaker 1: Part one and Part two that's out now and there
- 4:58Speaker 1: will be links in our show notes, all right, like
- 5:01Speaker 1: I promised. Alan McGill is a senior supervisory special Agent.
- 5:07Speaker 1: He's currently signed to the Office of Public Engagement in
- 5:11Speaker 1: the State of Pennsylvania and this is part of the
- 5:14Speaker 1: Attorney General's Department and program. I've known Allen for years
- 5:19Speaker 1: and he's going to give us some insight into non
- 5:24Speaker 1: non opioid, non controlled substances that are being diverted in
- 5:31Speaker 1: how there are issues with that. Before we get into that,
- 5:35Speaker 1: did you hear there is a pharmacist that used to
- 5:39Speaker 1: work for Walgreens. This made national news on cn CNBC.
- 5:47Speaker 1: I don't read much of CNBC's news anymore. I really
- 5:51Speaker 1: follow them more on Twitter, but I did come across
- 5:55Speaker 1: this really fun story and it's a shout out to
- 5:59Speaker 1: a pharmacist doing something different. But the headline is she
- 6:02Speaker 1: quit her job as a Walgreens pharmacist to start a
- 6:06Speaker 1: Vietnamese coffee company and today it brings in over five
- 6:10Speaker 1: hundred thousand dollars a year. This is quite the success
- 6:14Speaker 1: story from doctor Lanhoe, founder of Fat Milk and it's Miilk,
- 6:22Speaker 1: And she was working as a Walgreens pharmacist earning about
- 6:27Speaker 1: one hundred and twenty thousand dollars a year. She built
- 6:31Speaker 1: this coffee company and now it's exceeded five hundred thousand
- 6:37Speaker 1: a year. And it just shows you that your passion
- 6:40Speaker 1: is not limited by a pharmacist career if you want
- 6:45Speaker 1: to get outside of pharmacy, but use all of your
- 6:48Speaker 1: connection to your background and your network. This is an
- 6:54Speaker 1: exciting story. So this came once again from the News
- 6:59Speaker 1: just this week. And excited to watch land Hoe do more.
- 7:05Speaker 1: Doctor Hoe, maybe we'll have you on twrqus talk to
- 7:08Speaker 1: us about coffee. I love coffee, so that'd be.
- 7:10Speaker 2: A good episode.
- 7:12Speaker 1: Hey, this is coming off of Fox News and the
- 7:15Speaker 1: headline is pharmacy chain closure one and fourteen stores closing
- 7:25Speaker 1: in the state of Pennsylvania. That's my state been hit
- 7:30Speaker 1: very hard with the closure of write aids and the
- 7:33Speaker 1: impact that's going to have on public health. Something more
- 7:38Speaker 1: in the good news is the next that comes from
- 7:41Speaker 1: Yahoo Finance. The title here is Clover Health, publicly traded
- 7:47Speaker 1: clov announced a new pharmacy pilot program in New Jersey.
- 7:52Speaker 1: We heard about this a week ago from our sponsor's
- 7:56Speaker 1: IPC in their I Care Plus program. This program is
- 8:01Speaker 1: aimed at helping seniors. It's a management that noted the
- 8:05Speaker 1: local pharmacies that are using icare and are part of
- 8:08Speaker 1: the I Care network will be the backbone of the
- 8:11Speaker 1: initiative and how using this platform to dig deeper into
- 8:15Speaker 1: patients' needs and more around seniors needs through remote patient
- 8:20Speaker 1: monitoring and telehealth is going to be a huge part
- 8:24Speaker 1: of the future of our independent community pharmacies. But this
- 8:27Speaker 1: made national news. The Clover Health system and plan is
- 8:33Speaker 1: now inserting I Care Plus into it and that is
- 8:35Speaker 1: a huge, huge, huge win for our independent community pharmacies.
- 8:41Speaker 1: If you're interested in learning more about i Care Plus,
- 8:44Speaker 1: please take a look at IPC site. Just go to
- 8:47Speaker 1: IPC dot com. Once again, that's IPC dot com. Our
- 8:52Speaker 1: ipcrx dot com That is ipcrx dot com. But wonderful
- 8:58Speaker 1: news from Clover Health and as a program embedding community
- 9:04Speaker 1: pharmacy into it through technology that they have through the
- 9:07Speaker 1: Icare Plus program. All Right, last news that just came
- 9:11Speaker 1: out today from the NCPA National Community Pharmacist Association applauds
- 9:17Speaker 1: a bill to reimburse pharmacists for treating covid flu and
- 9:21Speaker 1: other elements. And how Doug Hoy was quoted saying that
- 9:27Speaker 1: this legislation protects patient access, especially for people in rural
- 9:31Speaker 1: areas where pharmacists can be the only healthcare provider for
- 9:35Speaker 1: many miles. An independent community pharmacists delivered tens of millions
- 9:40Speaker 1: of doses of COVID nineteen vaccine during the pandemic. They
- 9:43Speaker 1: saved the lives of countless Americans who would not have
- 9:46Speaker 1: gotten the vaccine without them. The legislation expands on that success.
- 9:52Speaker 1: And this is called the Equitable Community Access to Pharmacist Services,
- 9:57Speaker 1: the ECAPS Act, and it was put into motion through
- 10:05Speaker 1: the efforts of Senator Mark Warner and Majority Leader Senate
- 10:10Speaker 1: Majority Leader John Thune. And this is good news for
- 10:15Speaker 1: independent community pharmacies. Shout out to you. Last on our
- 10:19Speaker 1: news comes from RX Insider, and it says con consorti X,
- 10:25Speaker 1: consorty X, State of the nation, state of the industry,
- 10:29Speaker 1: leveraging DSCSA to improve operations and how it's important with
- 10:35Speaker 1: the recent FDA town hall which was hosted in advance
- 10:40Speaker 1: of the coming wholesaler enforcement date, and this date will
- 10:44Speaker 1: go into effect as of August twenty seventh, twenty twenty five,
- 10:48Speaker 1: that's coming up very soon. Once again, if you want
- 10:51Speaker 1: to learn more about that, go to rxinsider dot com
- 10:55Speaker 1: and go to their product awareness section and it's an overview,
- 11:00Speaker 1: it's a webinar. It's done out by consorti X and
- 11:05Speaker 1: just a shout out to them for keeping us informed.
- 11:08Speaker 1: And we'll be doing more with ARX Insider coming in
- 11:12Speaker 1: the future, leveraging a lot of the reports and insight
- 11:16Speaker 1: reports that they're doing, including a follow up to the
- 11:19Speaker 1: careers report that we reported on that we reported on,
- 11:22Speaker 1: the report of the report of the report. How many
- 11:24Speaker 1: times can I say the word report? Goodness gracious, but yeah,
- 11:28Speaker 1: that'll be exciting to extend that information that we're getting
- 11:32Speaker 1: from the ARCS Insider's team. I do want to just
- 11:38Speaker 1: say special thank you to al Migil. He drove from Erie, Pennsylvania,
- 11:44Speaker 1: down to our studios in Brownsville. That's about a two
- 11:46Speaker 1: and a half hour drive to do this update on
- 11:52Speaker 1: non controlled substances and diversion and how important it is
- 11:58Speaker 1: to be aware of that. While controlled substances are typically
- 12:02Speaker 1: the focus in drug diversion discussions, several non controlled medications
- 12:08Speaker 1: also pose significant risk for misuse and abuse, and due
- 12:12Speaker 1: to their unscheduled status, these drugs are often subject to
- 12:16Speaker 1: less stringent monitoring despite growing evidence of non therapeutic use, dependency,
- 12:22Speaker 1: and harm. Many of these medications are routinely stocked and
- 12:26Speaker 1: administered in veterinarian clinics, and ongoing misuse could result in
- 12:30Speaker 1: future scheduling or increase regulatory oversight. Non controlled drugs with
- 12:37Speaker 1: known emerging potential misuse or abuse and will have some
- 12:41Speaker 1: of those that are included from this interview with Special
- 12:47Speaker 1: Agent Alan McGill, Senior Supervisor, Special Agent, currently assigned to
- 12:52Speaker 1: the Office of Public Engagement. This is a amazing update
- 12:56Speaker 1: and we're excited to bring this to you on this
- 13:00Speaker 1: week in pharmacy.
- 13:02Speaker 3: One of the things that had come up and I
- 13:04Speaker 3: was doing trainings for hospital systems and for pharmacists, and
- 13:10Speaker 3: I've been doing it for since twenty twelve, I think,
- 13:13Speaker 3: is how long I've been doing these presentations and trainings.
- 13:16Speaker 3: And I was at a hospital system in northwestern Pennsylvania
- 13:20Speaker 3: and I was doing a training for their staff. And
- 13:22Speaker 3: after the training was over, the pharmacy manager, the pharmacy
- 13:28Speaker 3: director had come over to me and said, you know, Ellen,
- 13:31Speaker 3: I have a shortage of promethese and can you explain
- 13:36Speaker 3: why somebody would would want that? And I said, are
- 13:40Speaker 3: you talking about promethese with codine and which is a
- 13:43Speaker 3: common drug for you know, students and schools. You know,
- 13:49Speaker 3: I mean it's also makes its rounds in the celebrity
- 13:51Speaker 3: circles and those sort of things too individ you know,
- 13:55Speaker 3: you might commonly think of it under nicknames like lean
- 13:59Speaker 3: or scissor or purple drank, things like that. And so
- 14:03Speaker 3: I had asked her and said, is that what you're
- 14:04Speaker 3: talking about? She said, no, I'm just talking about straight promath.
- 14:08Speaker 3: And she said, can you think of any recause you
- 14:10Speaker 3: can't get high from it? So she said, can you
- 14:11Speaker 3: think of any reason why somebody would want to steal
- 14:15Speaker 3: that because I have a shortage of it in the
- 14:16Speaker 3: pharmacy here at the hospital. And I said, well, the
- 14:19Speaker 3: only thing that comes to mind is that that is
- 14:25Speaker 3: something that will alleviate at least one symptom of withdrawal.
- 14:30Speaker 3: And so since withdrawal symptoms are you know, they're very painful.
- 14:34Speaker 3: So I mean, it's experiencing it, going through it so
- 14:39Speaker 3: and nausea and vomiting is a part of that, and
- 14:41Speaker 3: so promethazine treats that. And so what I'd said to
- 14:46Speaker 3: her is, like I said a moment ago, is you
- 14:50Speaker 3: probably have somebody on staff that is suffering from a
- 14:53Speaker 3: substitute disorder. They're trying to self treat, and so they're
- 14:59Speaker 3: stealing promethazine in order to do that. And that's been
- 15:04Speaker 3: a common thing that I've had occurred during a lot
- 15:07Speaker 3: of the investigations that I ran, where you would have
- 15:11Speaker 3: a pharmacist or a healthcare professional, nurse, whoever it is,
- 15:16Speaker 3: that tries to self treat their.
- 15:18Speaker 2: Substance use disorder.
- 15:19Speaker 3: They don't want to be discovered, they don't want anybody
- 15:21Speaker 3: to know, they don't want to risk their job, and
- 15:24Speaker 3: so they will take just about anything, and they'll get
- 15:27Speaker 3: into the polypharmacy a little bit.
- 15:29Speaker 2: And this occurred with.
- 15:31Speaker 3: A pharmacist that I had arrested as well, and I
- 15:34Speaker 3: hadn't really thought about it.
- 15:35Speaker 2: A whole lot when I was doing.
- 15:36Speaker 3: When I initially started doing the trainings, I mainly focused
- 15:39Speaker 3: on the controlled substances and stealing those security measures to
- 15:45Speaker 3: put in place to make sure we can account and
- 15:47Speaker 3: track for those. And I had arrested this pharmacist and
- 15:53Speaker 3: a couple of years later, I had asked.
- 15:54Speaker 2: Her to do a.
- 15:56Speaker 3: On camera interview with me so I could use it
- 15:59Speaker 3: in my training segments. And one of the videos that
- 16:02Speaker 3: she did, she talked about that she had developed a
- 16:06Speaker 3: substance use disorder to the point she'd become addicted to
- 16:09Speaker 3: viking In and she was taking vico in in, you know,
- 16:16Speaker 3: ten at a time. She would take a handful and
- 16:17Speaker 3: use ten at a time, and she would do that
- 16:19Speaker 3: sometimes two, three, four times a day. So we're talking
- 16:21Speaker 3: about forty pain pills and she was taken. So that was,
- 16:24Speaker 3: you know, that was not something that was that unusual
- 16:26Speaker 3: in the diversion end of things. But what I found
- 16:29Speaker 3: interesting in her video, and I play this video a
- 16:31Speaker 3: lot when I do trainings, she talked about how there
- 16:34Speaker 3: was one point where she was at the register and
- 16:36Speaker 3: she was nodding off. She couldn't keep her eyes open
- 16:39Speaker 3: because she had taken so many of the open and
- 16:42Speaker 3: so she ended up looking for a way to counter that,
- 16:46Speaker 3: and she decides she would take provigil you know, for
- 16:50Speaker 3: anarcalypsy and so, you know, to get her a bit,
- 16:52Speaker 3: she said, but then her heart started.
- 16:53Speaker 2: Thumping, you know, just pounding away.
- 16:56Speaker 3: So she took blood pressure medication, which is I know,
- 17:00Speaker 3: so she takes that, and then then she you know,
- 17:03Speaker 3: dipped into the benzeotazepines and she went through this whole
- 17:05Speaker 3: litany of different drugs that she had tried. And one
- 17:09Speaker 3: of the things that I also, you know, I point
- 17:11Speaker 3: out to a lot of folks is that, you know,
- 17:13Speaker 3: when it comes to healthcare practitioners, they're very often they're dedicators.
- 17:18Speaker 3: You know, they know what the drugs do, they know,
- 17:21Speaker 3: you know, what the effects are and those sort of things,
- 17:23Speaker 3: so they will they're comfortable taking it and trying to
- 17:26Speaker 3: treat themselves. And this happens a lot with people that
- 17:29Speaker 3: suffer from substitute disorder. They don't want to be discovered,
- 17:32Speaker 3: so they're looking for a way to counterdat. And so
- 17:35Speaker 3: going back to the prometheesne that was I think was
- 17:37Speaker 3: one of the things that was happening. And interestingly enough,
- 17:40Speaker 3: I was just when I was doing this segment this
- 17:43Speaker 3: presentation at NASCA, I was talking to one of the
- 17:47Speaker 3: Prescription Drug Monitoring program directors out of South Carolina, and
- 17:52Speaker 3: she said, they're having an issue in South Carolina where
- 17:55Speaker 3: they have individuals that are actually illicitly obtaining it from pharmacies.
- 18:01Speaker 3: And I think one of the things that happens is
- 18:04Speaker 3: that we get so focused on guarding the controlled substances
- 18:09Speaker 3: we sometimes ignore the non controls, and the non controlleds
- 18:12Speaker 3: can just be a clue. Now I should say, I'm
- 18:15Speaker 3: not suggesting this is widespread, or this is an epidemic
- 18:18Speaker 3: or anything like that. I'm just pointing out that non
- 18:21Speaker 3: controls can be a marker to detect if you have
- 18:24Speaker 3: someone with that condition, which can lead to maybe undiscovered
- 18:29Speaker 3: diversion that's occurring in your facilities. So as an investigator,
- 18:32Speaker 3: it's worth paying attention to if you see something, you know,
- 18:35Speaker 3: like that pharmacy director asking me about you know, promath
- 18:39Speaker 3: you know, was an important clue that they have an issue.
- 18:42Speaker 3: So in South Carolina, what they have is a lot
- 18:45Speaker 3: of the pharmacies are pulling back dispensing promethesm with coding.
- 18:50Speaker 3: And the reason that that's occurred is there was a
- 18:52Speaker 3: progression in this when I was still in diversion, when
- 18:55Speaker 3: I was a supervisor, we had some groups that were
- 18:58Speaker 3: traveling across the East and seaboard of the United States
- 19:02Speaker 3: that were going into pharmacies and they were either illegally
- 19:04Speaker 3: calling in pro methasine with coding or they were forging prescriptions.
- 19:09Speaker 3: And what it happened was they would do that, the
- 19:12Speaker 3: pharmacies would catch on, they would call law enforcement like us.
- 19:16Speaker 3: Then we would post up somewhere around the pharmacy and
- 19:19Speaker 3: we'd wait from them. We'd snag them when they came in. So,
- 19:23Speaker 3: you know, criminals are always thinking of a way to
- 19:25Speaker 3: get around whatever measures we put in place. So what
- 19:30Speaker 3: started to happen was then instead of calling it in
- 19:33Speaker 3: and lurting anybody, they started showing up more and more
- 19:37Speaker 3: towards the evening hours, especially when the pharmacy was about
- 19:40Speaker 3: ready to close, so that law enforcement wouldn't get the
- 19:44Speaker 3: heads up or get the advance to arrest them. And
- 19:47Speaker 3: then they just started jumping counters. They started just going
- 19:52Speaker 3: over to the counters and putting pharmacists at risk. So
- 19:54Speaker 3: a lot of the pharmacies didn't want to carry for
- 19:58Speaker 3: methasm with coding for one thing, it's easy to see,
- 20:02Speaker 3: and street value can making those high as one thousand
- 20:05Speaker 3: dollars a pint, sometimes a lot less, just depends on
- 20:08Speaker 3: the market, but it can go that high. So if
- 20:10Speaker 3: you think about it from a gang or criminal gang's perspective,
- 20:15Speaker 3: if you see three or four bottles up on a
- 20:18Speaker 3: pharmacy shelf because it's only a Schedule five and you
- 20:20Speaker 3: see it sitting there, that's easy pickings. That makes more
- 20:23Speaker 3: sense to go jump that counter and take those than
- 20:25Speaker 3: it would to try the safe systems that they have
- 20:28Speaker 3: in place and those sort of things. So in order
- 20:31Speaker 3: to counter that, a lot of the pharmacies were stopped
- 20:34Speaker 3: stalking pro methasm with coding, and what they found is
- 20:38Speaker 3: now they have to revert to straight pro meth. So
- 20:41Speaker 3: what a lot of the individuals are doing is they'll
- 20:43Speaker 3: look to gain access somehow illegally to the promethazine and
- 20:47Speaker 3: then you just combine it with another drug outside of
- 20:50Speaker 3: that so they can mimic that street drug. So those
- 20:53Speaker 3: are you know, that's something. But the main thrust of
- 20:58Speaker 3: what I know this presentation or what I talk about
- 21:01Speaker 3: is if it alleviates any symptom of withdrawal, any symptom
- 21:05Speaker 3: of withdrawal. Then it's going to be a drug that's
- 21:08Speaker 3: going to be subject to be instolen, and so it's
- 21:10Speaker 3: something to kind of pay a little closer attention attention to.
- 21:15Speaker 3: You know, there are lots of drugs, including the non controls,
- 21:18Speaker 3: that can potentiate the effects of controls, and so that
- 21:22Speaker 3: becomes another reason too to look for this. I can
- 21:25Speaker 3: remember talking to patients at the method Ande Clinic in Eerie,
- 21:30Speaker 3: and at that time I forget what drug they were after,
- 21:34Speaker 3: but I asked them, I said, why are you doing that?
- 21:37Speaker 3: You know, I think it was bugspray or something, and
- 21:39Speaker 3: I said, why are you messing around bug spray? And
- 21:42Speaker 3: they said, well, you know, as doctors have pulled back
- 21:45Speaker 3: on how many medications.
- 21:47Speaker 2: They prescribed to us, we're still addicted.
- 21:50Speaker 3: And so they're looking for anything that could potentiate the
- 21:53Speaker 3: effect of an opioid or a benzo or another drug
- 21:57Speaker 3: that they have, and so they'll go to a long
- 21:59Speaker 3: can And of course, you know, with the Internet today,
- 22:03Speaker 3: people can go into chat rooms, they can go into
- 22:06Speaker 3: just do Google Google searches and they can find those
- 22:08Speaker 3: kinds of things, you know, so they can learn from
- 22:11Speaker 3: each other, so that becomes another reason that they do
- 22:14Speaker 3: it too. So, you know, alleviate any withdrawal symptom is
- 22:19Speaker 3: my you know, So what I tell pharmacies or pharmacists
- 22:22Speaker 3: is you know the drugs better than we do. You know,
- 22:25Speaker 3: I'm just a I'm just a dumb cop. So I
- 22:27Speaker 3: have to catch up, you know, I have to learn
- 22:30Speaker 3: as I go, whereas they know what the drugs are
- 22:32Speaker 3: and what the new ones that are coming out. So
- 22:33Speaker 3: if there is a drug that is going to potentiate
- 22:35Speaker 3: the effect of a controlled substance, or if it can
- 22:40Speaker 3: alleviate any withdrawal symptom, then that's a that's a drug
- 22:43Speaker 3: to pay attention to that. You know, if it becomes
- 22:45Speaker 3: a missing are of shortages, that can be a clue
- 22:48Speaker 3: as to maybe you have an issue or a problem
- 22:52Speaker 3: within your system. And so it's just something to kind
- 22:54Speaker 3: of pay attention to that way as well. And so
- 22:58Speaker 3: you know, withdrawal symptoms can you know, they vary of
- 23:00Speaker 3: course from and I would say probably the ones I
- 23:03Speaker 3: paid closest attention to or opiod withdrawal, benzo withdrawal, and
- 23:07Speaker 3: then stimulant withdrawal, and so you know they're they're pretty similar.
- 23:11Speaker 3: But you know, they're all about the same, but there's
- 23:14Speaker 3: a few things that kind of go out of that.
- 23:16Speaker 3: So looking for those kind of things is what you're
- 23:19Speaker 3: after when it comes to hospital systems, you know, just
- 23:23Speaker 3: some of the drugs that that they're you know, usually
- 23:27Speaker 3: we're trying to encourage them to pay attention to, for example,
- 23:30Speaker 3: be like propofol. Propofol is not a controlled substance, and
- 23:35Speaker 3: not surprising, the vast majority of shortages of propofol are
- 23:38Speaker 3: going to exist with antithesiologists or CRNAs, so you know,
- 23:44Speaker 3: just paying attention to those. As I already mentioned, you know,
- 23:47Speaker 3: straight promath is another one. On edestrine or zofran is
- 23:52Speaker 3: also one that is used to treat nausea and em vomiting,
- 23:55Speaker 3: generally thought of in circles of chemotherapy and those sort
- 23:58Speaker 3: of things. So that's going to be one that could
- 24:01Speaker 3: be subject to be stolen too. And you know, part
- 24:05Speaker 3: of the other problem is it probably not going to
- 24:07Speaker 3: be stolen in large quantities, you know, so it might
- 24:10Speaker 3: be easy to miss, you know, that sort of thing,
- 24:13Speaker 3: so but it can be you know, something to pay.
- 24:17Speaker 3: And then methyl nel tres oone or releas store is
- 24:22Speaker 3: another one.
- 24:23Speaker 2: Too.
- 24:23Speaker 3: Now that's used to treat opiate induced constipation, so also
- 24:27Speaker 3: something very uncomfortable, so you know, and you know, depending
- 24:31Speaker 3: on costs of different drugs like this one could be expensive.
- 24:34Speaker 3: So you might have individuals inside the system healthcare system
- 24:38Speaker 3: that say, you know, this is something that you know,
- 24:41Speaker 3: I want to take in order to alleviate you know,
- 24:44Speaker 3: that point of withdrawal as well. And along a similar line,
- 24:50Speaker 3: another one that comes up, It's come up a couple
- 24:52Speaker 3: of times is la paramnd or emodium. I have a
- 24:57Speaker 3: friend of mine, she's a CRNP at the VA, and
- 25:02Speaker 3: she had told me it was about I think it
- 25:03Speaker 3: was about six months ago that a patient had presented
- 25:07Speaker 3: and he admitted it taking two hundred milligrams of amodium
- 25:11Speaker 3: every day to get high. Because if you take it
- 25:13Speaker 3: in the large quantities, you can get a reaction high
- 25:16Speaker 3: and get high from it. Seventy milligrams is supposed to
- 25:19Speaker 3: be on the high side, so imagine taking two hundred milligrams.
- 25:22Speaker 2: And the other thing that this.
- 25:23Speaker 3: Does too is you know individuals that you know or
- 25:27Speaker 3: are looking they're looking to treat, you know, some sort
- 25:30Speaker 3: of symptom, but they're also not in any danger of
- 25:33Speaker 3: getting arrested, at least not theoretically, you know, because it's
- 25:36Speaker 3: not a controlled substance, and so because of that, you know,
- 25:40Speaker 3: that's another reason they want to do it too, because
- 25:41Speaker 3: they don't have to worry about getting arrested, but they
- 25:43Speaker 3: can achieve the same same effects. So you know, that's
- 25:47Speaker 3: one to and we've had to come up a couple
- 25:49Speaker 3: of times. Oddly enough. You know, it came up a
- 25:53Speaker 3: couple of years back, and I kind of dismissed it
- 25:56Speaker 3: as a one off. But now when you hear it
- 25:58Speaker 3: again and you start hearing a couple more cases of
- 26:00Speaker 3: the country, it's just something to pay attention to, you know,
- 26:03Speaker 3: when I when I train law enforcement and I do
- 26:08Speaker 3: anything along those lines, especially if it has to do
- 26:10Speaker 3: with patrol or even during search horns. You know, if
- 26:12Speaker 3: you if you walk into somebody's house and they got
- 26:14Speaker 3: boxes of a modium, then you clearly have got somebody
- 26:18Speaker 3: with a substance use disorder. And it could be anything
- 26:20Speaker 3: where you walk into any kind of situation and just
- 26:23Speaker 3: see notice that. So it's just things to kind of
- 26:25Speaker 3: pay attention to. Another one, Sarah quill Is a is
- 26:31Speaker 3: one that is also subject to be to be taken well,
- 26:37Speaker 3: and it could potentiate the effects of benzodazepines. So, you know,
- 26:41Speaker 3: if you have someone that develops an addiction to a
- 26:45Speaker 3: benzo such as you know, Xanax or valume or any
- 26:49Speaker 3: ada van or something along those lines, and they're suddenly
- 26:52Speaker 3: getting weaned down from their doctor or you know, the
- 26:57Speaker 3: you're not getting as many as they used to get,
- 26:58Speaker 3: or however they want, and they can convince someone to
- 27:02Speaker 3: prescribe them seraquill, then they can potentially at the.
- 27:05Speaker 2: Effects of what they already have in existence.
- 27:08Speaker 3: And the other thing too, and there can be a
- 27:09Speaker 3: market for this, even though I said, you know, really
- 27:12Speaker 3: I don't expect to be widespreader or high volume of losses.
- 27:17Speaker 3: But one things that folks do to have a substance
- 27:20Speaker 3: use disorder, especially on street usage, is you know, this
- 27:23Speaker 3: becomes currency as well. So if they can steal a
- 27:26Speaker 3: bunch of it and they can trade it for another
- 27:29Speaker 3: drug of choice or something like that, and people that
- 27:32Speaker 3: want to maybe have something on hand in case they
- 27:34Speaker 3: can't get as much as they want, it becomes another
- 27:37Speaker 3: reason to do that too. You know, another drug that
- 27:41Speaker 3: and I included in the presentation is called a teaser lamb,
- 27:45Speaker 3: and so a teaser lamb is actually emergency scheduled.
- 27:48Speaker 2: Right now, I think it still is to double check it.
- 27:51Speaker 3: But a teaser lamb is, you know, is an illicit
- 27:54Speaker 3: benzodazepine that is not proof for any medical use in
- 27:59Speaker 3: the United States. And we started to see it show
- 28:03Speaker 3: up in different forms. One form was in counterfeit pills,
- 28:08Speaker 3: and so they would take Xanax bars. Instead of having
- 28:13Speaker 3: it have any xanax, it would actually have a teaser
- 28:16Speaker 3: lamb instead, and the teas lamb is not.
- 28:18Speaker 2: A safe drug in the United States.
- 28:20Speaker 3: So and then another form that we had in the
- 28:23Speaker 3: central part of Pennsylvania was we had a case involving
- 28:28Speaker 3: this was when I was still a supervisor. A woman
- 28:31Speaker 3: had purchased some earth excuse me, been a woman. A
- 28:34Speaker 3: gentleman had purchased some out of New York City, some
- 28:38Speaker 3: pills and then they were actually pez candy and they.
- 28:41Speaker 2: Were coded with a teaser lamb.
- 28:43Speaker 3: And he had given them to a third grader and
- 28:47Speaker 3: the sixth grader, and they almost died. He was babysitting,
- 28:51Speaker 3: you know, he wanted them to go to sleep. They
- 28:52Speaker 3: had a lot of energy, these two little girls, and
- 28:54Speaker 3: he gave thought would be a good idea to give
- 28:56Speaker 3: them each a couple of pez candy coated with a
- 28:59Speaker 3: teaser lamb.
- 29:00Speaker 2: So you know, it's just.
- 29:02Speaker 3: But it's not a regularly you know, it hasn't been confirmed.
- 29:05Speaker 3: It's just been emergency scheduled, you know. Well, bututrin is
- 29:10Speaker 3: another one that comes up from time to time as well,
- 29:13Speaker 3: so that one, you know, it has it's an amphetamine analog,
- 29:18Speaker 3: so it can have similar stimulant effects. It's another one
- 29:22Speaker 3: one of the things that I noticed, and like I
- 29:24Speaker 3: said earlier with my example about talking to you know,
- 29:27Speaker 3: folks at the methadone clinic, what they will tell you
- 29:30Speaker 3: is they'll take anything. And this is true for healthcare
- 29:32Speaker 3: professionals too. They're going to be willing to take anything
- 29:35Speaker 3: to avoid withdrawal because it's so painful. So it's gonna
- 29:38Speaker 3: be a stimulant, it can be a benzo non control,
- 29:40Speaker 3: whatever it is. One that I think is particularly attractive
- 29:46Speaker 3: of a non control is quantitine. Qlantidine will actually treat
- 29:50Speaker 3: all of the symptoms of opioid withdrawal. And so you know,
- 29:54Speaker 3: if you're a medical professional and you have access to
- 29:57Speaker 3: quantitine and you're going to start suffering through sort of withdrawal,
- 30:01Speaker 3: and that can be something to be attractive to take
- 30:05Speaker 3: as well. And then of course we have gabapentin, which
- 30:09Speaker 3: is a non controlled now depending on how far out
- 30:12Speaker 3: your your listening audiences, there are some states that do
- 30:14Speaker 3: have it controlled and some states actually have it where
- 30:18Speaker 3: it is requirement is that is dispensing is uploaded to
- 30:23Speaker 3: their PDMP, their Prescription Drug Monitoring Program.
- 30:26Speaker 2: Which I think is a good thing.
- 30:28Speaker 3: We don't have anything like that in Pennsylvania that I'm
- 30:30Speaker 3: aware of. So, you know, gabapentin is one that is
- 30:34Speaker 3: widely abused and most people are pretty familiar with that now.
- 30:39Speaker 3: It's also a drug that is used in the veterinarian
- 30:41Speaker 3: space as well because it's very effective painkiller for dogs
- 30:45Speaker 3: and cats, and so that's another drug that we keep
- 30:50Speaker 3: an eye on too. And then just some ones that
- 30:54Speaker 3: you know, one that comes up all the time that
- 30:56Speaker 3: probably should mention too is Cretum is not in the
- 31:00Speaker 3: legal substance. It's not regulated by the FDA or anybody else.
- 31:05Speaker 3: But the problem with with creatim is there have been
- 31:07Speaker 3: cases across the US where there have been deaths associated
- 31:10Speaker 3: with creatim. Now, people that are pro creative are going
- 31:13Speaker 3: to tell you that you know it's not you. There
- 31:15Speaker 3: have been no deaths by creative itself, and that could
- 31:18Speaker 3: be true.
- 31:19Speaker 2: I don't know that.
- 31:19Speaker 3: I just know that there have been cases where it
- 31:22Speaker 3: has come up in the toxicology where they have creative
- 31:25Speaker 3: in the system. The other part of the problem is,
- 31:28Speaker 3: because it's not regulated, how do we really verify what's
- 31:31Speaker 3: in it? So you know, you could you right here
- 31:35Speaker 3: could be a creatium creative manufacturer, produce your own creative
- 31:38Speaker 3: in this little studio if you wanted to, and press
- 31:40Speaker 3: them into pills, and there's no regulations on it, So
- 31:44Speaker 3: how would I verify that what you're selling me is
- 31:47Speaker 3: actually creative and not tainted with something else?
- 31:50Speaker 2: Right? So, and then of course you know the one.
- 31:54Speaker 3: That everybody is really familiar with, of course, xylazine, which
- 31:59Speaker 3: is the veterinarian medication that everybody thinks of as the
- 32:03Speaker 3: zombie drug that gets you know, mixed in with fentanyl
- 32:06Speaker 3: a lot.
- 32:06Speaker 2: And that's true, that's.
- 32:07Speaker 3: Emergency scheduled by the DEA too, so I don't usually
- 32:11Speaker 3: talk about that. But the newer one is metatomidine, and
- 32:15Speaker 3: so metatobinine is also another veterinarian medication that's used to
- 32:21Speaker 3: treat animals, but we're starting to see that show up
- 32:24Speaker 3: in samples, especially out East and the Philadelphia in those areas,
- 32:28Speaker 3: so metatomadine becomes one. So individuals that are looking maybe
- 32:33Speaker 3: for clues is to you know, individuals looking to sell
- 32:38Speaker 3: or make money in that space, that's what we would
- 32:41Speaker 3: look at. So you know, really, you know, there's a
- 32:47Speaker 3: whole wide variety of different controlled substances. But you know
- 32:51Speaker 3: what I would say in what I encourage pharmacy directors
- 32:54Speaker 3: and pharmacists is, you know, you know the drugs better
- 32:57Speaker 3: than we do, and just pay attention to the ones
- 33:01Speaker 3: that can alleviate any sort of symptom from withdrawal, even
- 33:04Speaker 3: if it's a non controlled You know, anything at all
- 33:09Speaker 3: would be helpful to help detect diversion.
- 33:12Speaker 1: Have you, over your years developed a reputation in a
- 33:16Speaker 1: network of pharmacists and pharmacy owners who will reach out
- 33:21Speaker 1: to you on occasion to ask your advice on something
- 33:24Speaker 1: that might seem strange to them.
- 33:26Speaker 3: Yeah, they do occasionally, but generally, since I've been in
- 33:30Speaker 3: this unit for a while now, they'll usually contact the
- 33:34Speaker 3: diversion unit with the Attorney General's Office or they'll contact
- 33:38Speaker 3: the diversion agents in the DEA because DEA has their
- 33:42Speaker 3: diversion agents too. I'm not so much talking about the
- 33:45Speaker 3: tactical diversion unit, but just the diversion agents that go
- 33:49Speaker 3: out and do inspections and also enforce those the CFRs too,
- 33:55Speaker 3: So it's waned off a little bit. I do have
- 33:58Speaker 3: people to contact me from time to time to ask
- 34:01Speaker 3: me about you know, I just had a doctor, for example,
- 34:04Speaker 3: call me the other day about he was involved with
- 34:09Speaker 3: a physicians group that prescribes ADHD medications and the pharmacies
- 34:15Speaker 3: for whatever reason, had a little bit of a concern
- 34:19Speaker 3: about it, and so they weren't filling his prescriptions. So
- 34:21Speaker 3: he was calling to ask my advice on that. I
- 34:24Speaker 3: get pharmacies that'll call and ask, you know, different questions about,
- 34:29Speaker 3: you know, any new regulations, telemedicine, those sort.
- 34:31Speaker 2: Of things that are coming up.
- 34:34Speaker 1: And working with the Attorney General. Are you able to
- 34:40Speaker 1: based on data, are you able to start seeing trends
- 34:43Speaker 1: appear in certain parts of the state and then kind
- 34:47Speaker 1: of like flags your team to make pharmacist or pharmacies
- 34:51Speaker 1: aware of something that might be happening.
- 34:53Speaker 3: Well, we don't have anything in place right now that
- 34:55Speaker 3: I'm aware of. Most of the time that will come
- 34:57Speaker 3: from the Prescription Drug Monitoring program, So they do have
- 35:01Speaker 3: ways to alert pharmacists in the prescription drug within their
- 35:06Speaker 3: system so they can look there. So they generally do that.
- 35:10Speaker 3: You know, we pass on what we can to pharmacies,
- 35:13Speaker 3: you know, whenever we can.
- 35:14Speaker 2: You know.
- 35:14Speaker 3: For example, one of the things that's been coming up
- 35:18Speaker 3: recently has been, you know.
- 35:19Speaker 2: The rise in the psychedelics. Okay, you know, so there's
- 35:24Speaker 2: a lot about it.
- 35:24Speaker 3: Yeah, so the psychedelic space, there's a lot, and I
- 35:28Speaker 3: think I had warned people probably about two years ago
- 35:31Speaker 3: when we start to see the more accepted medical use
- 35:34Speaker 3: for it, which you know is great, you know, I
- 35:37Speaker 3: have no issue with that, but the warning is that
- 35:40Speaker 3: when you see that, you're going to see more of
- 35:42Speaker 3: it illicitly. Not so worried, not worried too much about
- 35:46Speaker 3: diversion in terms of how it's administered, as I understand
- 35:50Speaker 3: the process. I'm not too concerned about that, but just
- 35:53Speaker 3: the fact that it's going to show up more on
- 35:55Speaker 3: the street. You know, there's going to be a demand
- 35:56Speaker 3: for it, individuals looking to make money. You're going to
- 36:00Speaker 3: make it available in all kinds of forms, and that's
- 36:03Speaker 3: what we're.
- 36:03Speaker 2: Starting to see. We're starting to see that more and more.
- 36:06Speaker 1: All right, So what's the best way If someone's listening
- 36:09Speaker 1: to you and they do want to reach out, they
- 36:11Speaker 1: want to get more information. Can we share your email
- 36:13Speaker 1: address up here?
- 36:14Speaker 2: You can?
- 36:15Speaker 3: The only the only thing about that is probably the
- 36:18Speaker 3: better ways to contact our office, the Attorney General's office.
- 36:22Speaker 3: You know, I tell folks all the time you can
- 36:23Speaker 3: call me, but I don't investigate cases anymore. I just
- 36:26Speaker 3: do trainings and presentations, so you know, I just try
- 36:30Speaker 3: and impart knowledge as best I can in crime prevention.
- 36:33Speaker 3: And what will happen is I'll have to hand them
- 36:35Speaker 3: off to somebody else. So you can show my email,
- 36:39Speaker 3: that's fine, you know they can see it. They can
- 36:41Speaker 3: certainly reach out to me if they have a question
- 36:44Speaker 3: or an issue, I will, you know, quarterback that and
- 36:46Speaker 3: get them to the right unit that sort of thing.
- 36:49Speaker 3: So if they want to skip that step in the
- 36:52Speaker 3: process and go right to the source, then they can
- 36:54Speaker 3: contact our office directly and just look for any Bureau
- 36:59Speaker 3: of Narcotics Investing gations local. They're eight across the state,
- 37:03Speaker 3: so they can contact any one of those and they'll
- 37:05Speaker 3: put them right to a diversion agent.
- 37:08Speaker 1: All right, So I don't I don't expect you to
- 37:10Speaker 1: have a crystal ball, but being a fellow Pittsburgh area
- 37:16Speaker 1: is ist and I ish ist. I guess is a word.
- 37:19Speaker 1: It doesn't even But you are a Steeler fan, So
- 37:22Speaker 1: what do you think is going to happen this season? Oh?
- 37:25Speaker 2: I thought you were not no offense to the Steeler nation.
- 37:29Speaker 3: But and I know they're going to cringe when they
- 37:31Speaker 3: hear this, but I'm actually a Cowboy fan.
- 37:33Speaker 2: Oh okay, so ever since I was a kid, and
- 37:35Speaker 2: really Roger.
- 37:36Speaker 3: Staubach is is how it got me into that. But
- 37:39Speaker 3: asking me a question about the Steelers something.
- 37:40Speaker 1: Yeah, I'm looking forward to the recreation of our team
- 37:44Speaker 1: this year and just adding some new players in. And
- 37:48Speaker 1: I'm nervous.
- 37:49Speaker 2: I don't.
- 37:49Speaker 1: I don't see like anything. I'm not going into this
- 37:52Speaker 1: season like I've gone into seasons five and ten years ago.
- 37:56Speaker 2: It's really hard.
- 37:57Speaker 3: I think probably without having a know, a leader, quarterback,
- 38:01Speaker 3: you know, having a defined you know, Ben Roethlisberger was
- 38:06Speaker 3: was here for so many years that it became sort
- 38:09Speaker 3: of just you know, I think you take it for
- 38:12Speaker 3: granted and all of a sudden, when when someone like that,
- 38:15Speaker 3: of that caliber and that talent is not there, then
- 38:18Speaker 3: who's going to fill that void? And so I don't
- 38:21Speaker 3: honestly know, you know, I don't even know did Aaron
- 38:23Speaker 3: Rodgers officially sign?
- 38:25Speaker 1: I thought so, but then I read something else that
- 38:27Speaker 1: there was some other negotiation happened. But yeah, I think
- 38:32Speaker 1: he'll I think he'll start for us.
- 38:34Speaker 3: That's going to be an interesting dynamic, you know, And
- 38:37Speaker 3: to see that happen, I'm curious about that. And I
- 38:42Speaker 3: have to say, just from a fans perspective, it may
- 38:45Speaker 3: not be a popular opinion. I'm kind of looking forward
- 38:47Speaker 3: to seeing that. Yeah, you know, because obviously he has
- 38:50Speaker 3: great talent, so I mean he was on the downside
- 38:53Speaker 3: of his, you know, his career.
- 38:55Speaker 2: But we'll see how it goes well.
- 38:57Speaker 1: We appreciate you coming down for the year office in
- 39:01Speaker 1: Medville area and driving down to the studio here in Brownsville.
- 39:04Speaker 1: You're welcome to definitely do a follow up. I get
- 39:07Speaker 1: to get up to the National Association that you actually
- 39:11Speaker 1: helped command in order to get some pharmacists more involved there.
- 39:14Speaker 1: What's the next event that will be taking place?
- 39:17Speaker 3: We did a drug Diversion and Healthcare conference this past April.
- 39:22Speaker 3: It's a local one that our office does with an
- 39:26Speaker 3: organization called BECAT, which stends for a Brockway Center for
- 39:29Speaker 3: the Arts and Technology, and BECAT actually is a nonprofit
- 39:34Speaker 3: that what they do is they provide pharmacy tech certification
- 39:39Speaker 3: and schooling for free. They only take I think about
- 39:42Speaker 3: fifteen students per class, but it's.
- 39:45Speaker 2: Mainly folks that you know.
- 39:47Speaker 3: They provide this service and you have to apply and
- 39:50Speaker 3: then you can become a pharmacy tech and they have
- 39:53Speaker 3: I think a good job placement program. And then they
- 39:57Speaker 3: also do medical assistant and forbottom which is really interesting.
- 40:02Speaker 3: So I was doing presentations for their pharmacy tech students
- 40:06Speaker 3: for a number of years and the executive director, Derek
- 40:09Speaker 3: Hanson and I, you know, we had his lead instructor,
- 40:15Speaker 3: Jessica Hummer. We had gotten together and talked about doing
- 40:19Speaker 3: a conference, and so we do. We had our third
- 40:22Speaker 3: annual conference in Erie, Pennsylvania. It was did very well.
- 40:26Speaker 3: We had over two hundred people registered and we had
- 40:29Speaker 3: one hundred and eighty I think it was one hundred
- 40:31Speaker 3: and eighty five people actually attended the conference. So it
- 40:34Speaker 3: was just a one day event. It was a great event.
- 40:36Speaker 3: We're looking to do it again next year. We're not
- 40:39Speaker 3: entirely sure. We did have it at pitt Titusville for
- 40:43Speaker 3: the first couple of years and it's a beautiful campus.
- 40:47Speaker 3: It's a great place to have it, but there just
- 40:49Speaker 3: isn't any the infrastructure, the hotels, or a good route
- 40:53Speaker 3: to get there, so it was a little bit harder.
- 40:55Speaker 3: So we only had about one hundred and twenty people
- 40:57Speaker 3: would show up at those and so we moved it
- 40:59Speaker 3: to Erie, had an explosion in the number of attendees
- 41:02Speaker 3: and had a lot of great subjects. And then this
- 41:06Speaker 3: year we're looking to put it and I'm not really sure.
- 41:08Speaker 3: We may go back to Eerie. We're looking at Grove
- 41:10Speaker 3: City area, somewhere that, you know, because because of eighty
- 41:13Speaker 3: and seventy nine, because of that intersection Ara, So we're
- 41:17Speaker 3: thinking about doing it somewhere around and are you know
- 41:20Speaker 3: Our Attorney General David Sunday came out and spoke for
- 41:24Speaker 3: us there. Fantastic lecture he did for us too, for
- 41:30Speaker 3: about twenty minutes to open it up for us, and
- 41:34Speaker 3: he's really a super I don't know if you had
- 41:36Speaker 3: ever a chance to meet him or hear him speak
- 41:38Speaker 3: or anything he does. He's really a down to earth guy.
- 41:41Speaker 3: And at the risk of sounding like I'm sucking up
- 41:44Speaker 3: to the boss, I'm going to say he you know,
- 41:46Speaker 3: I've been with the office for twenty seven years. I've
- 41:48Speaker 3: worked for I think eight or nine attorney generals, and
- 41:52Speaker 3: he's by far the best one that I've seen. CEDI
- 41:55Speaker 3: bar Yeah, you really, really really admire him. He has
- 41:58Speaker 3: a great campaign. He campaigned on what he calls accountability
- 42:04Speaker 3: and redemption. Those are the things he believes in. And
- 42:07Speaker 3: I really like that because as a diversion agent, one
- 42:11Speaker 3: of the things that I always talked about was trying
- 42:13Speaker 3: to get people help because the vast majority of healthcare
- 42:17Speaker 3: professionals are not criminals. You know, they are people that
- 42:22Speaker 3: fall into a substance use disorder and they end up
- 42:26Speaker 3: crossing lines they never would have imagined. They're not bad people,
- 42:31Speaker 3: and so you know they but we have to hold
- 42:33Speaker 3: them accountable and there has to be a redemption. We
- 42:36Speaker 3: got to get him to the point where we get
- 42:37Speaker 3: them back so and get their careers back. And so
- 42:39Speaker 3: I built my career on that premise. So when I
- 42:42Speaker 3: heard him talking about that and expressing that, I thought, well,
- 42:46Speaker 3: you know, finally I've got an Attorney General that you know,
- 42:49Speaker 3: I'm proud to really work for, and so I'm really
- 42:52Speaker 3: happy about that. I'm excited to see what he's going
- 42:56Speaker 3: to do over the next four to eight years. And
- 43:00Speaker 3: you know, just a good guy.
- 43:01Speaker 2: You know.
- 43:02Speaker 3: Hopefully we can get him down here and have a
- 43:03Speaker 3: conversation with you or maybe even on a zoom or something.
- 43:07Speaker 2: Right.
- 43:07Speaker 1: Absolutely, Alan McGill, this has been terrific. Thank you so
- 43:11Speaker 1: much for being on this Week in Pharmacy.
- 43:13Speaker 2: Thank you very much for having me.
- 43:14Speaker 1: Hey this Week in Pharmacy listeners. We will be right back.
- 43:21Speaker 1: What an interesting interview with Alan McGill. Shout out to you, Alan,
- 43:27Speaker 1: thanks for giving us this information on non controlled substances
- 43:33Speaker 1: and what an interesting update. I didn't even think of
- 43:38Speaker 1: half of those things that I'm sure pharmacists out there listening.
- 43:41Speaker 1: Pharmacy owners, you're getting some refreshers, so that was wonderful.
- 43:46Speaker 1: Before we wrap up, I want to give a shout
- 43:49Speaker 1: out to the big news that was coming from Idea
- 43:52Speaker 1: Share twenty twenty five. We were there as press support
- 43:56Speaker 1: in the IPCs booth Independent Pharmacy Cooperative. But the big
- 44:00Speaker 1: news is celebrating one of the health maarts out there,
- 44:05Speaker 1: Dave's Pharmacy of Alliance, Nebraska. Dave is a Pharmacy fifty
- 44:12Speaker 1: Award winner, one of the most influential people in our
- 44:15Speaker 1: pharmacy industry, voted on by his peers. Dave Randolph, I
- 44:20Speaker 1: want to say congratulations. You've been given the honor of
- 44:26Speaker 1: the Pharmacy of the Year twenty twenty five. Shout out
- 44:29Speaker 1: to you, Dave, and just want to applaud you and
- 44:33Speaker 1: say congratulations. And I'm sure that that means quite a lot,
- 44:37Speaker 1: not only to your pharmacy and your staff, but to
- 44:40Speaker 1: your community and hopefully your community appreciates that achievement. Hey,
- 44:45Speaker 1: we are excited about what's coming the rest of this month.
- 44:50Speaker 1: You have to stay tuned this week in pharmacy. If
- 44:52Speaker 1: you have anything that you'd like to talk about that
- 44:55Speaker 1: isn't being reviewed or we are not getting enough attention,
- 44:58Speaker 1: please reach out to me personally. My email is Uri
- 45:02Speaker 1: eu r Y at Pharmacy podcast dot com. That's Yuri,
- 45:07Speaker 1: that's eu r Y at pharmacypodcast dot com. And you know,
- 45:13Speaker 1: thank you so much for listening, thank you for everything
- 45:16Speaker 1: that you do as pharmacists. And we'll talk to you
- 45:19Speaker 1: next week.